For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
When the elephant in the room won’t leave
+Miscellany
In print
When the elephant in the room won’t leave
Thursday 2 May 2024, 12:29 PM

We like to think that COVID is in the rearview mirror when it’s very much in the passenger’s seat, with its big, elephantine feet up on the dash [Image: Kaffeebart on Unsplash]
Alan Perrott with the third instalment of the COVID Chronicles
It’s getting harder to understand the cloak of invisibility that clings to elephants in rooms.
And by elephants, I, of course, mean bloody COVID.
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.